BERLIN, Germany, July 27, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that it will host a conference call in English for its second quarter and first half 2005 financial and operating results, and other corporate developments, on Wednesday, August 3, 2005 at 3.00pm CET (9.00am EDT). A live Webcast of the conference call can be accessed at www.epigenomics.com.
The conference call and the Webcast are open to all interested parties.
An archived version of the Webcast will be available at Epigenomics' website in the Investor Relations section for three months. A replay of the conference call also will be available for 48 hours, beginning 1 hour after the completion of the live call.
Epigenomics AG will announce its second quarter and first half 2005 financial and operating results on Wednesday, August 3, 2005, before the opening of regular market trading hours.
Dial-In Numbers for the call are as follows:
Germany +49 (0)69 2222 2246 UK +44 (0)20 7365 1849 (UK) USA +1 718 354 1172
Dial-in Numbers and Passcode for the conference call replay are:
Germany +49 (0)69 22222 0418 UK +44 (0)207 784 1024 USA +1 718 354 1112 Replay Passcode: 2874969#
About Epigenomics
Epigenomics is a molecular diagnostics company with a focus on the development of novel products for cancer. By detecting and interpreting DNA methylation patterns, Epigenomics' tests can potentially diagnose disease at an early stage and help guide physicians to select an appropriate therapy. Epigenomics collaborates with Roche Diagnostics on the development of several diagnostic products in cancer. The company has its headquarters in Berlin, Germany, and a wholly owned subsidiary in Seattle, USA. For more information, please visit our website at www.epigenomics.com.